欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/1058/001
药品名称Treprostinil Orpha-Devel 1 mg/ml solution for infusion
活性成分
    • treprostinil 1.0 mg/ml
剂型Solution for infusion
上市许可持有人Orpha-Devel Handels und Vertriebs GmbH Wintergasse 85/B 3002 Purkersdorf Austria
参考成员国 - 产品名称Austria (AT)
Treprostinil Orpha-Devel 1 mg/ml Infusionslösung
互认成员国 - 产品名称
    • Croatia (HR)
      Tresuvi 1 mg/ml otopina za infuziju
    • Germany (DE)
      Tresuvi 1 mg/ml Infusionslösung
    • Belgium (BE)
      Tresuvi 1 mg/ml solution pour perfusion
    • Netherlands (NL)
    • Ireland (IE)
    • France (FR)
    • Italy (IT)
    • Sweden (SE)
    • Latvia (LV)
      Treposuvi 1 mg/ml šķīdums infūzijām
    • Lithuania (LT)
      Tresuvi 1 mg/ml infuzinis tirpalas
    • Estonia (EE)
      TRESUVI
    • Malta (MT)
      Tresuvi Solution for Infusion 1mg/ml
许可日期2020/11/27
最近更新日期2024/07/19
药物ATC编码
    • B01AC21 treprostinil
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase